Skip to main content
Signal8

GELSTAT CORP (GSAC)

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

GelStat Corporation logo

GelStat Corporation

OTC:GSACHealthcare
$0.0003
Mkt Cap$185K
Float530.21M
O/S617.98M
Inst Own-
SI<0.1%
Dilution